Variable | Deficiency (n = 29) | Non-deficiency (n = 71) | P-value |
---|---|---|---|
Age, years | 57.52 ± 8.10 | 59.68 ± 8.61 | 0.098 |
Gender | Â | Â | <0.001 |
 Male | 4 (13.8) | 39 (54.9) |  |
 Female | 25 (86.2) | 32 (45.1) |  |
Race | Â | Â | 0.001 |
 Malay | 17 (58.6) | 33 (46.5) |  |
 Chinese | 2 (6.9) | 28 (39.4) |  |
 Indian | 10 (34.5) | 10 (14.1) |  |
Weight, kg | 75.56 ± 20.24 | 73.30 ± 15.51 | 0.764 |
Height, cm | 161.24 ± 7.88 | 162.36 ± 8.19 | 0.534 |
BMI, kg/m2 | 28.92 ± 6.86 | 27.84 ± 5.28 | 0.401 |
Smokers | 1 (3.4) | 18 (25.4) | 0.011 |
Diabetes mellitus | 24 (82.8) | 52 (73.2) | 0.440 |
Hypertension | 26 (89.7) | 67 (94.4) | 0.410 |
Dyslipidemia | 23 (79.3) | 56 (78.9) | 1.000 |
 Total cholesterol, mmol/L | 4.81 ± 1.75 | 4.29 ± 1.16 | 0.111 |
 Triglyceride, mmol/L | 2.06 ± 0.97 | 1.70 ± 0.69 | 0.093 |
 HDL Cholesterol, mmol/L | 1.22 ± 0.40 | 1.19 ± 0.32 | 0.920 |
 LDL Cholesterol, mmol/L | 2.70 ± 1.53 | 2.33 ± 0.99 | 0.244 |
CKD | Â | Â | 0.450 |
 Stage 3A | 6 (20.7) | 23 (32.4) |  |
 Stage 3B | 12 (41.4) | 28 (39.4) |  |
 Stage 4 | 11 (37.9) | 20 (28.2) |  |
Urea, mmol/L | 9.18 ± 3.34 | 10.08 ± 3.46 | 0.196 |
Creatinine, mmol/L | 165.21 ± 61.38 | 168.61 ± 56.30 | 0.587 |
eGFR, mls/min/1.73 m2 | 34.17 ± 11.58 | 37.44 ± 12.28 | 0.223 |
Hemoglobin, g/dL | 11.28 ± 1.60 | 12.23 ± 1.77 | 0.014 |
Ca2+, mmol/L | 2.26 ± 0.10 | 2.27 ± 0.11 | 0.678 |
PO42-, mmol/L | 1.31 ± 0.21 | 1.22 ± 0.23 | 0.038 |
PTH, pmol/L | 11.49 ± 10.33 | 6.33 ± 3.97 | 0.014 |
25(OH)D, nmol/L | 13.76 ± 6.31 | 50.48 ± 17.30 | <0.001 |